Novo Nordisk launches COPI, a 250M DKK initiative to combat childhood obesity in disadvantaged urban communities, partnering with local governments, academia, and non-profits.

Novo Nordisk has introduced the Childhood Obesity Prevention Initiative (COPI) to combat obesity in children aged 6-13 from disadvantaged urban communities across six cities worldwide. With an investment exceeding 250 million Danish kroner over three years, the initiative partners with local governments, academic institutions, and non-profits to promote physical activity and healthy eating. It aims to evaluate interventions based on a robust evidence-based framework.

October 08, 2024
5 Articles